Cellectis (CLLS) Common Equity: 2014-2023
- Cellectis' Common Equity was N/A to $76.1 million in Q3 2023 from the same period last year, while for Sep 2023 it was $76.1 million, marking a year-over-year change of. This contributed to the annual value of $7.2 million for FY2022, which is 48.82% down from last year.
- Per Cellectis' latest filing, its Common Equity stood at $76.1 million for Q3 2023, which was down 21.16% from $96.6 million recorded in Q2 2023.
- In the past 5 years, Cellectis' Common Equity registered a high of $315.1 million during Q4 2019, and its lowest value of $16.7 million during Q1 2022.
- Its 3-year average for Common Equity is $110.4 million, with a median of $96.6 million in 2023.
- Data for Cellectis' Common Equity shows a maximum YoY tumbled of 46.74% (in 2022) over the last 5 years.
- Over the past 5 years, Cellectis' Common Equity (Quarterly) stood at $315.1 million in 2019, then declined by 1.99% to $308.8 million in 2020, then fell by 23.43% to $236.5 million in 2021, then slumped by 46.74% to $125.9 million in 2022, then reached $76.1 million in 2023.
- Its Common Equity stands at $76.1 million for Q3 2023, versus $96.6 million for Q2 2023 and $125.9 million for Q4 2022.
